Stock data
RxSight, Inc. (RXST)
RxSight, Inc. (RXST) reported revenue of US$134.48M and net income of -US$38.94M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$134.48M | US$103.01M | -US$48.19M | -US$38.94M | — |
| 2024 | US$139.93M | US$98.94M | -US$36.86M | -US$27.45M | — |
| 2023 | US$89.08M | US$53.77M | -US$50.09M | -US$48.61M | — |
| 2022 | US$49.01M | US$21.33M | -US$63.32M | -US$66.76M | — |
| 2021 | US$22.59M | US$4.52M | -US$52.79M | -US$48.69M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$27.24M | -US$12.10M | — |
| 2026-03-31 | US$30.89M | -US$15.88M | — |
| 2025-12-31 | US$32.61M | -US$9.15M | — |
| 2025-09-30 | US$30.34M | -US$9.82M | — |
| 2025-06-30 | US$33.64M | -US$11.79M | — |
| 2025-03-31 | US$37.90M | -US$8.19M | — |
| 2024-12-31 | US$40.21M | -US$5.94M | — |
| 2024-09-30 | US$35.31M | -US$6.34M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.